High Intensity Laser Therapy (HILT) High intensity laser therapy harnesses targeted light energy via the processes of photomodulation and thermomodulation to stimulate healing in damaged tissues
BPC-157 modulates the nitric oxide system, promotes angiogenesis through VEGFR2 signaling, and shows strong GI mucosal protection
Reconstituted vials must be labelled with the date and time of preparation, concentration, and beyond-use date in accordance with the protocol and local aseptic policy
Compounded medications: Not approved for humans at all
partial sequence of human Body Protection Compound Sequence: H-Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val-OH (GEPPPGKPADDAGLV) Synonyms: PL 14736, PLD-116 CAS Number: 137525-51-0 Molecular Formula: C 62 H 98 N 16 O 22 Molecular Weight: 1419.55 g/mol Mechanism (working): modulation of nitric oxide system, VEGFR-2 expression, and growth factor signaling supporting GI, vascular, and connective-tissue repair Regulatory status: not approved by the FDA or EMA TB-500 Compound class: synthetic N-acetylated heptapeptide
